Biao Xi
21Patents
7h-index
10Co-inventors
62Inventor score
Filing activity: Jul 17, 2008 → Nov 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8252822B2 | Heterocyclic compounds and uses as anticancer agents | Chemistry; Metallurgy | 23 | Active |
| US9612234B2 | Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments | Physics | 18 | Active |
| US9709548B2 | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution | Physics | 16 | Active |
| US10012636B2 | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution | Physics | 12 | Active |
| US9034885B2 | EGFR modulators and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US8685988B2 | EGFR modulators and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US9464089B2 | Heterocyclic compounds and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US10533985B2 | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution | Physics | 7 | Active |
| US9763949B2 | EGFR modulators and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9586965B2 | Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases | Human Necessities | 7 | Active |
| US9920074B2 | Heterocyclic compounds and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US10596174B2 | Pyrrolopyrimidine compounds as inhibitors of protein kinases | Chemistry; Metallurgy | 3 | Active |
| US10449196B2 | EGFR modulators and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10562918B2 | Heterocyclic compounds and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10551371B2 | System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function | Physics | 3 | Active |
| US10799504B2 | Heterocyclic compounds and uses as anticancer agents | Chemistry; Metallurgy | 2 | Active |
| US11007197B2 | EGFR modulators and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11360072B2 | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution | Physics | 0 | Active |
| US11612602B2 | Heterocyclic compounds and uses as anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US9623027B2 | EGFR modulators and uses thereof | General | 0 | Revoked |
| US11906508B2 | Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.